Adrenal Bone Cardiovascular Diabetes Endocrine-Disrupting Chemicals Endocrine-Related Cancer Metabolism Neuroendocrinology Obesity Reproduction Steroid and Steroidogenesis Thyroid
Calling all clinicians, clinician-scientists and biomedical researchers to complete the 'State of Endocrinology 2025 Survey' - this is your chance to raise your voice!
A widely used hormone treatment, Cyproterone acetate (CPA), has come under scrutiny following studies linking high-dose or long-term use to a sharply increased risk of meningioma, a type of brain tumor. European research suggests a 6- to 20-fold rise in risk, potentially due to the drug's stimulation of hormone receptors found in certain brain regions.